BioCryst Pharmaceuticals
BCRX
#4706
Rank
C$2.24 B
Marketcap
$10.82
Share price
1.43%
Change (1 day)
56.43%
Change (1 year)

BioCryst Pharmaceuticals (BCRX) - Total debt

Total debt on the balance sheet as of June 2024 : C$1.14 Billion

According to BioCryst Pharmaceuticals 's latest financial reports the company's total debt is C$1.14 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

BioCryst Pharmaceuticals - Total debt on balance sheet (from 1996 to 2024)

Total debt by year

Year Total debt Change
2023-12-31C$1.09 B8.78%
2022-12-31C$1.00 B33.08%
2021-12-31C$0.75 B112.14%
2020-12-31C$0.35 B222.34%
2019-12-31C$0.11 B31.28%
2018-12-31C$84.21 M22.41%
2017-12-31C$68.79 M-4.71%
2016-12-31C$72.19 M72.45%
2015-12-31C$41.86 M20.25%
2014-12-31C$34.81 M9.02%
2013-12-31C$31.93 M7.05%
2012-12-31C$29.83 M-2.24%
2011-12-31C$30.51 M
2000-12-31C$0.01 M
1997-12-31C$0.14 M-65.23%
1996-12-31C$0.41 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
C$1.03 B-9.59%๐Ÿ‡บ๐Ÿ‡ธ USA
C$1.90 B 66.72%๐Ÿ‡บ๐Ÿ‡ธ USA
C$2.08 M-99.82%๐Ÿ‡บ๐Ÿ‡ธ USA
C$0.32 B-71.61%๐Ÿ‡บ๐Ÿ‡ธ USA
C$32.47 B 2,741.78%๐Ÿ‡บ๐Ÿ‡ธ USA
C$3.31 M-99.71%๐Ÿ‡บ๐Ÿ‡ธ USA
C$29.89 B 2,515.68%๐Ÿ‡ฌ๐Ÿ‡ง UK
C$1.19 B 4.93%๐Ÿ‡บ๐Ÿ‡ธ USA
C$16.87 M-98.52%๐Ÿ‡บ๐Ÿ‡ธ USA